Mood & Mental Health

·

Study

First Psilocybin Therapy Trial for Prolonged Grief After Cancer Loss

First Psilocybin Therapy Trial for Prolonged Grief After Cancer Loss

Psilocybin mushrooms

What they found

The PARTING trial will give 15 people a 25 mg psilocybin dose plus therapy for prolonged grief after cancer loss.

The PARTING trial will give 15 people a 25 mg psilocybin dose plus therapy for prolonged grief after cancer loss.

The number

25 mg dose

How solid is it?

Early human

Early human

Evidence ladder: Lab dish → Animal → Early human → Strong human. Reviews summarize earlier research.

At a glance

Latin name

Compound

psilocybin

psilocybin

Sample size

Fifteen participants

Fifteen participants

Published in

BMJ Open

BMJ Open

Covered in Shroom Scan

Section

PSILOCYBIN & LEGISLATION

PSILOCYBIN & LEGISLATION

As it ran in Shroom Scan

Grief Relief Support

Grief Relief Support

The PARTING trial is the first clinical study to explore psilocybin-assisted psychotherapy for prolonged grief disorder (PGD) following cancer loss. Fifteen participants will receive a 25 mg dose of psilocybin combined with 7 psychotherapy sessions over 5 weeks. Researchers aim to assess whether this approach is safe, tolerable, and emotionally impactful over a 12-month follow-up.

The PARTING trial is the first clinical study to explore psilocybin-assisted psychotherapy for prolonged grief disorder (PGD) following cancer loss. Fifteen participants will receive a 25 mg dose of psilocybin combined with 7 psychotherapy sessions over 5 weeks. Researchers aim to assess whether this approach is safe, tolerable, and emotionally impactful over a 12-month follow-up.

Healing Mushrooms, Addiction Breakthroughs, and Plastic-Free Packaging

Read the original study ↗

Get Shroom Scan

Next study

Oyster Mushroom Mycelium Makes Plastic-Free Packaging ›

Shroom Scan · Every Friday

Get Studies Like This, Translated, Every Week

Ten new studies a week, each boiled down to what it found and why it matters to you. Free, and one click to leave.

See what's inside →